Advertisement
Pharmaceuticals and Biotech
Subscribe to Pharmaceuticals and Biotech

The Lead

Biotech Drugmaker Amgen Laying Off At Least 2,400

July 29, 2014 11:27 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that ...             

$1,000 Pill Now Treatment Of Choice

July 29, 2014 8:40 am | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment...

China To Put Glaxo Investigators On Trial In August

July 29, 2014 8:37 am | News | Comments

A Shanghai court says American and British investigators who worked for drug maker...

Drug Maker Fights Pediatricians' New Advice

July 28, 2014 10:38 am | by Lindsey Tanner, AP Medical Writer | News | Comments

A costly drug given mostly to premature babies is at the center of a clash between the...

View Sample

FREE Email Newsletter

Daily news and top headlines for manufacturing professionals

U.S. Executions Marked By Challenges, Drug Shortages

July 25, 2014 8:03 am | News | Comments

After more than three decades of using the same three-drug combo to put hundreds of inmates to death with few problems, states have scrambled in recent years to find alternative drugs because of a shortage rooted in European opposition to capital punishment.

FDA Reviewing What Might Become First Biosimilar Drug

July 25, 2014 7:51 am | News | Comments

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug.                   

Texas Firm Recalls Compounded Drugs

July 24, 2014 7:56 am | News | Comments

The Food and Drug Administration is warning doctors not to use compounded drugs from a Texas specialty pharmacy due to risks of contamination.                     

Advertisement

Inspection Finds Issues At GSK Vaccine Plant

July 23, 2014 10:10 am | by Helen Branswell, The Canadian Press | News | Comments

A recent Health Canada inspection of the country's only flu vaccine production plant identified 10 issues that need to be addressed, a report from the regulatory agency reveals.               

Allergan To Cut 1,500 Jobs

July 21, 2014 10:17 am | by Tom Murphy, AP Business Writer | News | Comments

Botox-maker Allergan says it is cutting about 13 percent of its workforce, or roughly 1,500 employees, as part of a push to become more efficient and productive.                      

AbbVie, Shire Agree On $55B Deal

July 18, 2014 7:58 am | by Tom Murphy, AP Business Writer | News | Comments

AbbVie has reached a roughly $55 billion deal to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from corporate income tax rates back home.                 

Novartis, Google To Develop 'Smart' Contact Lens

July 15, 2014 8:56 am | News | Comments

Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.                       

China Indicts Corporate Investigators Involved In GSK Probe

July 15, 2014 8:25 am | News | Comments

Humphrey and Yu are part of an industry of investigators who help corporate clients screen potential partners and employees or watch for embezzlement and other employee misconduct.                 

Advertisement

Mylan Buying Abbott Business Line In $5.3B Deal

July 14, 2014 8:25 am | News | Comments

The generic drug maker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion.                         

Gov. Patrick Signs Compounding Pharmacy Oversight Changes

July 11, 2014 7:46 am | News | Comments

The measure had been in the works for nearly two years, since a nationwide meningitis outbreak linked to the now-closed New England Compounding Center in Framingham. A tainted steroid produced by the company was blamed for 64 deaths and hundreds of illnesses.

FDA Approves First Drug From Anacor Pharma

July 9, 2014 2:32 pm | News | Comments

Shares of Anacor Pharmaceuticals Inc. climbed after federal regulators approved its first drug, the toenail fungus treatment Kerydin, a few weeks ahead of schedule.               

EU Fines Drug Makers $580M

July 9, 2014 8:08 am | News | Comments

The European Union's antitrust body is imposing a fine of $580 million on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.            

AbbVie Raises Bid For Shire

July 8, 2014 9:35 am | News | Comments

U.S. drugmaker AbbVie is boosting its offer for Shire by 11 percent to about $51.3 billion, hoping it will be enough to pique the interest of its British counterpart.              

Advertisement

Roche Buying Seragon For Up To $1.7B

July 2, 2014 9:28 am | News | Comments

Roche Holding AG says its U.S.-based biotech company Genentech has agreed to acquire American biotechnology firm Seragon Pharmaceuticals, Inc. for up to $1.725 billion in cash and contingency payments.              

Actavis Closes $28B Forest Deal

July 1, 2014 1:02 pm | News | Comments

Actavis has completed its $28 billion acquisition of fellow drugmaker Forest Laboratories, and the leader of the acquired company is now the CEO of Actavis.                 

Mass. Lawmakers Pass Compounding Pharmacy Oversight Bill

July 1, 2014 7:58 am | by Steve LeBlanc, Associated Press | News | Comments

The bill stemmed from a nationwide meningitis outbreak that authorities blamed on a tainted steroid produced by the now-closed New England Compounding Center in Framingham. The outbreak resulted in 64 deaths and hundreds of illnesses.    

Manufacturing.net Rewind: Obama's Lawsuit; Jobs From China

June 27, 2014 12:52 pm | News | Comments

Check out some of this week's top headlines from across Manufacturing.net, from the House planning to sue Obama for failing to carry out the laws passed by Congress to China creating thousands of U.S. jobs.             

Panel Says Flu Spray Better Than Shots For Young Kids

June 26, 2014 8:14 am | by Mike Stobbe, AP Medical Writer | News | Comments

When it comes to flu vaccines, a federal panel says a squirt in the nose is better than a shot in the arm for young children.                         

Acne Products May Cause Potentially Deadly Reactions

June 26, 2014 7:42 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health officials are warning consumers who use popular anti-acne treatments about rare but potentially deadly allergic reactions that can cause swelling of the face and difficulty breathing.            

USDA Gives Initial Approval To Pig Virus Vaccine

June 25, 2014 11:21 pm | by M.L. Johnson, Associated Press | News | Comments

Porcine epidemic diarrhea has killed millions of baby pigs since it showed up in the United States last year, and pork prices have been rising for months. For consumers, the worst may be yet to come because the most deaths happened last winter. 

GSK Warned Over Problems At Quebec Plant

June 25, 2014 7:45 am | by Helen Branswell, The Canadian Press | News | Comments

GSK received a letter of warning from the FDA about conditions at its manufacturing facility at Ste-Foy, Que., where the company makes flu vaccine for the Canadian and U.S. markets.               

Panel: 'Serious Faults' In Novartis Clinical Study

June 24, 2014 9:42 am | News | Comments

Novartis Pharma K.K. violated Japan's personal information protection law and ethical guidelines in a clinical study, led by the University of Tokyo, of a leukemia drug, the university's investigation panel said Tuesday.            

Shire Rejects $46.2B Offer From AbbVie

June 23, 2014 8:29 am | News | Comments

Dublin-based drugmaker Shire said it has rejected an unsolicited $46.2 billion offer from AbbVie Inc., arguing that it fundamentally undervalues the company and its prospects.             

Merck Drops Development Of Endocyte Cancer Drug

June 18, 2014 2:09 pm | News | Comments

Biotech drugmaker Endocyte said Tuesday it has regained rights to an experimental cancer drug from Merck & Co., after the treatment failed in a key study last month.                   

Valeant Makes Hostile $53B Bid For Allergan

June 18, 2014 11:35 am | News | Comments

Valeant, which is based in Canada, has teamed up with Bill Ackman's Pershing Square Capital Management to try to purchase Allergan. The two companies went public with their takeover attempt in April and have increased their offer several times.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading